Sarah Yuan

Sarah Yuan currently serves as the Chief Technology Officer at Cabaletta Bio. Prior roles include Chief Technical Operations Officer at Sigilon Therapeutics, Inc., VP of Process and Analytical Development at both 2seventy bio and bluebird bio, and Head of Manufacturing for Rare Blood Disease at Sanofi. Sarah Yuan has pursued education at Babson College since 2015 and at the Center for Creative Leadership since 2011.